They are also, without exception, animal studies a rescue-of-deficiency model in mice is not evidence of benefit in healthy humans
The aim of this trial was to investigate whether a GLP-1 RA as compared with placebo reduces fluid intake in patients with primary polydipsia
Here is what the company reported: Participants in SURMOUNT-3, after 12 weeks of intensive lifestyle intervention, achieved an additional 21.1% mean weight loss with tirzepatide for a total mean weight loss of 26.6% from study entry over 84 weeks Participants in SURMOUNT-4 achieved 21.1% weight loss during a 36-week tirzepatide lead-in period and an additional 6.7% weight loss during a 52-week continued treatment period, for a total mean weight loss of 26.0% over 88 weeks. How Does Zepbound Compare to Wegovy
Justin Carlson (right) presented a lecture, " Beyond the Guidelines: Sacubitril/Valsartan (ARNi) (Entresto) ", in which he reported on 49 case studies of MVD-affected dogs in late Stage C or Stage D ("pretty bad cases that I thought were not going to do very well"), 7 of which were cavalier King Charles spaniels (and 7 Maltese and 6 Yorkies)
Am Heart J 2011
They may have to determine if the interaction is worth the benefit of using both drugs or if your therapeutic plan needs to be changed